+ Filter
Loading...
Bapineuzumab
Loading...Anti-Bapineuzumab Products
- Recombinant Anti-human bapi Antibody (MOB-100)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: IgG
- Application: ELISA, WB, IP, FuncS
Compare
- Recombinant Anti-human bapi Antibody scFv Fragment (MOB-100-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: WB, IHC, FuncS
Compare
- Recombinant Human Anti-human bapi Antibody scFv Fragment (MHH-100-S(P))
-
- Derivation: Human
- Species Reactivity: Human
- Type: scFv
- Application: FC, Neut, Biosensors, FuncS
Compare
- Recombinant Human Anti-human bapi Antibody Fab Fragment (MHH-100-F(E))
-
- Derivation: Human
- Species Reactivity: Human
- Type: Fab
- Application: FC, RIA, Biosensors, FuncS
Compare
- Recombinant Anti-human bapi Antibody Fab Fragment (MOB-100-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: ELISA, FuncS
Compare
- DrugMonitor™ Anti-Bapineuzumab Antibody (VS-1224-YC159) (VS-1224-YC159)
-
- Specificity: Bapineuzumab
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, PK/PD, ADA control
Compare
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Bapineuzumab (nicknamed "bapi") is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and phosphorylated Tau protein in CSF.
Bapineuzumab has been investigated in clinical studies for treating Alzheimer's Disease.